Straumann Holding AG Other Long-Term Assets 2012-2024 | SAUHY

Straumann Holding AG other long-term assets from 2012 to 2024. Other long-term assets can be defined as field containing the sum of all non-current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
  • Straumann Holding AG other long-term assets for the quarter ending December 31, 2024 were $0.028B, a 144.05% increase year-over-year.
  • Straumann Holding AG other long-term assets for 2024 were $0B, a 0% decline from 2023.
  • Straumann Holding AG other long-term assets for 2023 were $0B, a 0% decline from 2022.
  • Straumann Holding AG other long-term assets for 2022 were $0B, a 0% decline from 2021.
Straumann Holding AG Annual Other Long-Term Assets
(Millions of US $)
2024 $0
2023 $0
2022 $0
2021 $0
2020 $0
2019 $0
2018 $0
2017 $0
2016 $0
2015 $0
2014 $0
2013 $1
2012 $3
2011 $3
Straumann Holding AG Quarterly Other Long-Term Assets
(Millions of US $)
2024-12-31 $28
2023-12-31 $29
2022-12-31 $22
2021-12-31 $18
2021-06-30 $12
2020-12-31 $9
2020-06-30 $7
2019-12-31 $7
2018-12-31 $6
2017-12-31 $6
2017-06-30 $6
2016-12-31 $4
2016-06-30 $4
2015-12-31 $3
2014-12-31 $1
2013-12-31 $1
2013-06-30 $1
2012-12-31 $3
2012-06-30 $3
2011-12-31 $3
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $21.152B $2.845B
The Straumann Group is a global leader in implant and restorative dentistry and oral tissue regeneration. In collaboration with leading clinics, research institutes and universities, Straumann researches, develops and manufactures dental implants, instruments, prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann currently employs approximately on thousand seven hundred ninety people worldwide and its products and services are available in more than sixty countries through its broad network of distribution subsidiaries and partners.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $89.979B 21.73
Becton Dickinson (BDX) United States $50.635B 12.54
Cardinal Health (CAH) United States $36.940B 19.35
Labcorp (LH) United States $20.992B 17.03
Cooper (COO) United States $16.298B 21.62
West Pharmaceutical Services (WST) United States $15.478B 32.44
Align Technology (ALGN) United States $13.234B 26.27
Henry Schein (HSIC) United States $8.901B 15.27
Merit Medical Systems (MMSI) United States $5.840B 28.23
DENTSPLY SIRONA (XRAY) United States $3.330B 9.95
CONMED (CNMD) United States $1.851B 13.85
STAAR Surgical (STAA) United States $0.953B 0.00
Lifevantage (LFVN) United States $0.167B 17.21
Pro-Dex (PDEX) United States $0.145B 15.92